Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 250

1.

Low frequency of flares during pregnancy and post-partum in stable lupus patients.

Davis-Porada J, Kim MY, Guerra MM, Laskin CA, Petri M, Lockshin MD, Sammaritano LR, Branch DW, Sawitzke A, Merrill JT, Buyon JP, Salmon JE.

Arthritis Res Ther. 2020 Mar 19;22(1):52. doi: 10.1186/s13075-020-2139-9.

2.

Sex Differences in Systemic Lupus Erythematosus: Epidemiology, Clinical Considerations, and Disease Pathogenesis.

Nusbaum JS, Mirza I, Shum J, Freilich RW, Cohen RE, Pillinger MH, Izmirly PM, Buyon JP.

Mayo Clin Proc. 2020 Feb;95(2):384-394. doi: 10.1016/j.mayocp.2019.09.012. Review.

PMID:
32029091
3.

Gerald Weissmann: Inflammation in rheumatic disease.

Cronstein BN, Buyon JP, Abramson SB.

Ann Rheum Dis. 2020 Apr;79(4):435-436. doi: 10.1136/annrheumdis-2019-216770. Epub 2020 Jan 22. No abstract available.

PMID:
31969327
4.

Salivary dysbiosis and the clinical spectrum in anti-Ro positive mothers of children with neonatal lupus.

Clancy RM, Marion MC, Ainsworth HC, Blaser MJ, Chang M, Howard TD, Izmirly PM, Lacher C, Masson M, Robins K, Buyon JP, Langefeld CD.

J Autoimmun. 2019 Oct 31:102354. doi: 10.1016/j.jaut.2019.102354. [Epub ahead of print]

PMID:
31677965
5.

Factors associated with long-term cardiac dysfunction in neonatal lupus.

Saxena A, Izmirly PM, Bomar RP, Golpanian RS, Friedman DM, Eisenberg R, Kim MY, Buyon JP.

Ann Rheum Dis. 2020 Feb;79(2):217-224. doi: 10.1136/annrheumdis-2019-215900. Epub 2019 Oct 31.

PMID:
31672776
6.

EULAR recommendations for the management of Sjögren's syndrome with topical and systemic therapies.

Ramos-Casals M, Brito-Zerón P, Bombardieri S, Bootsma H, De Vita S, Dörner T, Fisher BA, Gottenberg JE, Hernandez-Molina G, Kocher A, Kostov B, Kruize AA, Mandl T, Ng WF, Retamozo S, Seror R, Shoenfeld Y, Sisó-Almirall A, Tzioufas AG, Vitali C, Bowman S, Mariette X; EULAR-Sjögren Syndrome Task Force Group.

Ann Rheum Dis. 2020 Jan;79(1):3-18. doi: 10.1136/annrheumdis-2019-216114. Epub 2019 Oct 31.

PMID:
31672775
7.

Cell atlas of the fetal human heart and implications for autoimmune-mediated congenital heart block.

Suryawanshi H, Clancy R, Morozov P, Halushka MK, Buyon JP, Tuschl T.

Cardiovasc Res. 2019 Oct 7. pii: cvz257. doi: 10.1093/cvr/cvz257. [Epub ahead of print]

PMID:
31589297
8.

A tribute to Gerald Weissmann (1930-2019).

Abramson SB, Anderson PJ, Buyon JP, Cronstein BN, Pederson T, Philips MR, Serhan CN.

J Clin Invest. 2019 Nov 1;129(11):4553-4555. doi: 10.1172/JCI133490. No abstract available.

9.

PD-1hiCXCR5- T peripheral helper cells promote B cell responses in lupus via MAF and IL-21.

Bocharnikov AV, Keegan J, Wacleche VS, Cao Y, Fonseka CY, Wang G, Muise ES, Zhang KX, Arazi A, Keras G, Li ZJ, Qu Y, Gurish MF, Petri M, Buyon JP, Putterman C, Wofsy D, James JA, Guthridge JM, Diamond B, Anolik JH, Mackey MF, Alves SE, Nigrovic PA, Costenbader KH, Brenner MB, Lederer JA, Rao DA; Accelerating Medicines Partnership (AMP) RA/SLE Network.

JCI Insight. 2019 Oct 17;4(20). pii: 130062. doi: 10.1172/jci.insight.130062.

10.

Publisher Correction: The immune cell landscape in kidneys of patients with lupus nephritis.

Arazi A, Rao DA, Berthier CC, Davidson A, Liu Y, Hoover PJ, Chicoine A, Eisenhaure TM, Jonsson AH, Li S, Lieb DJ, Zhang F, Slowikowski K, Browne EP, Noma A, Sutherby D, Steelman S, Smilek DE, Tosta P, Apruzzese W, Massarotti E, Dall'Era M, Park M, Kamen DL, Furie RA, Payan-Schober F, Pendergraft WF 3rd, McInnis EA, Buyon JP, Petri MA, Putterman C, Kalunian KC, Woodle ES, Lederer JA, Hildeman DA, Nusbaum C, Raychaudhuri S, Kretzler M, Anolik JH, Brenner MB, Wofsy D, Hacohen N, Diamond B; Accelerating Medicines Partnership in SLE network.

Nat Immunol. 2019 Oct;20(10):1404. doi: 10.1038/s41590-019-0473-3.

PMID:
31409923
11.

Keeping upbeat to prevent the heartbreak of anti-Ro/SSA pregnancy.

Cuneo BF, Buyon JP.

Ultrasound Obstet Gynecol. 2019 Jul;54(1):7-9. doi: 10.1002/uog.20361.

PMID:
31313868
12.

Systemic Lupus Erythematosus and Increased Prevalence of Atherosclerotic Cardiovascular Disease in Hospitalized Patients.

Katz G, Smilowitz NR, Blazer A, Clancy R, Buyon JP, Berger JS.

Mayo Clin Proc. 2019 Aug;94(8):1436-1443. doi: 10.1016/j.mayocp.2019.01.044. Epub 2019 Jul 11.

PMID:
31303426
13.

The immune cell landscape in kidneys of patients with lupus nephritis.

Arazi A, Rao DA, Berthier CC, Davidson A, Liu Y, Hoover PJ, Chicoine A, Eisenhaure TM, Jonsson AH, Li S, Lieb DJ, Zhang F, Slowikowski K, Browne EP, Noma A, Sutherby D, Steelman S, Smilek DE, Tosta P, Apruzzese W, Massarotti E, Dall'Era M, Park M, Kamen DL, Furie RA, Payan-Schober F, Pendergraft WF 3rd, McInnis EA, Buyon JP, Petri MA, Putterman C, Kalunian KC, Woodle ES, Lederer JA, Hildeman DA, Nusbaum C, Raychaudhuri S, Kretzler M, Anolik JH, Brenner MB, Wofsy D, Hacohen N, Diamond B; Accelerating Medicines Partnership in SLE network.

Nat Immunol. 2019 Jul;20(7):902-914. doi: 10.1038/s41590-019-0398-x. Epub 2019 Jun 17. Erratum in: Nat Immunol. 2019 Aug 13;:.

14.

SLE: reconciling heterogeneity.

Lockshin MD, Barbhaiya M, Izmirly P, Buyon JP, Crow MK.

Lupus Sci Med. 2019 Feb 4;6(1):e000280. doi: 10.1136/lupus-2018-000280. eCollection 2019. No abstract available.

15.

Longitudinal profiling of human blood transcriptome in healthy and lupus pregnancy.

Hong S, Banchereau R, Maslow BL, Guerra MM, Cardenas J, Baisch J, Branch DW, Porter TF, Sawitzke A, Laskin CA, Buyon JP, Merrill J, Sammaritano LR, Petri M, Gatewood E, Cepika AM, Ohouo M, Obermoser G, Anguiano E, Kim TW, Nulsen J, Nehar-Belaid D, Blankenship D, Turner J, Banchereau J, Salmon JE, Pascual V.

J Exp Med. 2019 May 6;216(5):1154-1169. doi: 10.1084/jem.20190185. Epub 2019 Apr 8.

16.

Lupus nephritis is linked to disease-activity associated expansions and immunity to a gut commensal.

Azzouz D, Omarbekova A, Heguy A, Schwudke D, Gisch N, Rovin BH, Caricchio R, Buyon JP, Alekseyenko AV, Silverman GJ.

Ann Rheum Dis. 2019 Jul;78(7):947-956. doi: 10.1136/annrheumdis-2018-214856. Epub 2019 Feb 19.

17.

Human low-affinity IgG receptor FcγRIIA polymorphism H131R associates with subclinical atherosclerosis and increased platelet activity in systemic lupus erythematosus.

Clancy R, El Bannoudi H, Rasmussen SE, Bornkamp N, Allen N, Dann R, Reynolds H, Buyon JP, Berger JS.

J Thromb Haemost. 2019 Mar;17(3):532-537. doi: 10.1111/jth.14385. Epub 2019 Feb 13.

18.

Low aspirin use and high prevalence of pre-eclampsia risk factors among pregnant women in a multinational SLE inception cohort.

Mendel A, Bernatsky SB, Hanly JG, Urowitz MB, Clarke AE, Romero-Diaz J, Gordon C, Bae SC, Wallace DJ, Merrill JT, Buyon JP, Isenberg DA, Rahman A, Ginzler EM, Petri M, Dooley MA, Fortin PR, Gladman DD, Steinsson K, Ramsey-Goldman R, Khamashta MA, Aranow C, Mackay M, Alarcón GS, Manzi S, Nived O, Jönsen A, Zoma AA, van Vollenhoven RF, Ramos-Casals M, Ruiz-Irastorza G, Lim S, Kalunian KC, Inanc M, Kamen DL, Peschken CA, Jacobsen S, Askanase A, Sanchez-Guerrero J, Bruce IN, Costedoat-Chalumeau N, Vinet É.

Ann Rheum Dis. 2019 Jul;78(7):1010-1012. doi: 10.1136/annrheumdis-2018-214434. Epub 2018 Dec 20. No abstract available.

19.

Siglec-1 Macrophages and the Contribution of IFN to the Development of Autoimmune Congenital Heart Block.

Clancy RM, Halushka M, Rasmussen SE, Lhakhang T, Chang M, Buyon JP.

J Immunol. 2019 Jan 1;202(1):48-55. doi: 10.4049/jimmunol.1800357. Epub 2018 Dec 5.

20.

Effect of in utero hydroxychloroquine exposure on the development of cutaneous neonatal lupus erythematosus.

Barsalou J, Costedoat-Chalumeau N, Berhanu A, Fors-Nieves C, Shah U, Brown P, Laskin CA, Morel N, Levesque K, Buyon JP, Silverman ED, Izmirly PM.

Ann Rheum Dis. 2018 Dec;77(12):1742-1749. doi: 10.1136/annrheumdis-2018-213718. Epub 2018 Oct 8.

21.

The Incidence and Prevalence of Adult Primary Sjögren's Syndrome in New York County.

Izmirly PM, Buyon JP, Wan I, Belmont HM, Sahl S, Salmon JE, Askanase A, Bathon JM, Geraldino-Pardilla L, Ali Y, Ginzler EM, Putterman C, Gordon C, Helmick CG, Parton H.

Arthritis Care Res (Hoboken). 2019 Jul;71(7):949-960. doi: 10.1002/acr.23707. Epub 2019 May 23.

PMID:
30044541
22.

Autoimmune reactivity to malondialdehyde adducts in systemic lupus erythematosus is associated with disease activity and nephritis.

Hardt U, Larsson A, Gunnarsson I, Clancy RM, Petri M, Buyon JP, Silverman GJ, Svenungsson E, Grönwall C.

Arthritis Res Ther. 2018 Feb 26;20(1):36. doi: 10.1186/s13075-018-1530-2.

23.

Complement activation predicts adverse pregnancy outcome in patients with systemic lupus erythematosus and/or antiphospholipid antibodies.

Kim MY, Guerra MM, Kaplowitz E, Laskin CA, Petri M, Branch DW, Lockshin MD, Sammaritano LR, Merrill JT, Porter TF, Sawitzke A, Lynch AM, Buyon JP, Salmon JE.

Ann Rheum Dis. 2018 Apr;77(4):549-555. doi: 10.1136/annrheumdis-2017-212224. Epub 2018 Jan 25.

24.

Systemic lupus erythematosus and the risk of perioperative major adverse cardiovascular events.

Smilowitz NR, Katz G, Buyon JP, Clancy RM, Berger JS.

J Thromb Thrombolysis. 2018 Jan;45(1):13-17. doi: 10.1007/s11239-017-1591-0.

25.

Association of Natural Killer Cell Ligand Polymorphism HLA-C Asn80Lys With the Development of Anti-SSA/Ro-Associated Congenital Heart Block.

Ainsworth HC, Marion MC, Bertero T, Brucato A, Cimaz R, Costedoat-Chalumeau N, Fredi M, Gaffney P, Kelly J, Levesque K, Maltret A, Morel N, Ramoni V, Ruffatti A, Langefeld CD, Buyon JP, Clancy RM.

Arthritis Rheumatol. 2017 Nov;69(11):2170-2174. doi: 10.1002/art.40228. Epub 2017 Oct 17.

26.

The Incidence and Prevalence of Systemic Lupus Erythematosus in New York County (Manhattan), New York: The Manhattan Lupus Surveillance Program.

Izmirly PM, Wan I, Sahl S, Buyon JP, Belmont HM, Salmon JE, Askanase A, Bathon JM, Geraldino-Pardilla L, Ali Y, Ginzler EM, Putterman C, Gordon C, Helmick CG, Parton H.

Arthritis Rheumatol. 2017 Oct;69(10):2006-2017. doi: 10.1002/art.40192. Epub 2017 Sep 10.

27.

Apolipoprotein L1 risk variants associate with prevalent atherosclerotic disease in African American systemic lupus erythematosus patients.

Blazer A, Wang B, Simpson D, Kirchhoff T, Heffron S, Clancy RM, Heguy A, Ray K, Snuderl M, Buyon JP.

PLoS One. 2017 Aug 29;12(8):e0182483. doi: 10.1371/journal.pone.0182483. eCollection 2017.

28.

Clinical and pathologic implications of extending the spectrum of maternal autoantibodies reactive with ribonucleoproteins associated with cutaneous and now cardiac neonatal lupus from SSA/Ro and SSB/La to U1RNP.

Izmirly PM, Halushka MK, Rosenberg AZ, Whelton S, Rais-Bahrami K, Nath DS, Parton H, Clancy RM, Rasmussen S, Saxena A, Buyon JP.

Autoimmun Rev. 2017 Sep;16(9):980-983. doi: 10.1016/j.autrev.2017.07.013. Epub 2017 Jul 12. Review.

PMID:
28709760
29.

Cardiac fibroblast transcriptome analyses support a role for interferogenic, profibrotic, and inflammatory genes in anti-SSA/Ro-associated congenital heart block.

Clancy RM, Markham AJ, Jackson T, Rasmussen SE, Blumenberg M, Buyon JP.

Am J Physiol Heart Circ Physiol. 2017 Sep 1;313(3):H631-H640. doi: 10.1152/ajpheart.00256.2017. Epub 2017 Jun 16.

30.

No histologic evidence of foetal cardiotoxicity following exposure to maternal hydroxychloroquine.

Friedman D, Lovig L, Halushka M, Clancy RM, Izmirly PM, Buyon JP.

Clin Exp Rheumatol. 2017 Sep-Oct;35(5):857-859. Epub 2017 Jun 6.

31.

Progress in the pathogenesis and treatment of cardiac manifestations of neonatal lupus.

Izmirly P, Saxena A, Buyon JP.

Curr Opin Rheumatol. 2017 Sep;29(5):467-472. doi: 10.1097/BOR.0000000000000414. Review.

32.

Contribution of Socioeconomic Status to Racial/Ethnic Disparities in Adverse Pregnancy Outcomes Among Women With Systemic Lupus Erythematosus.

Kaplowitz ET, Ferguson S, Guerra M, Laskin CA, Buyon JP, Petri M, Lockshin MD, Sammaritano LR, Branch DW, Merrill JT, Katz P, Salmon JE.

Arthritis Care Res (Hoboken). 2018 Feb;70(2):230-235. doi: 10.1002/acr.23263. Epub 2017 Dec 29.

33.

Single cell RNA sequencing to dissect the molecular heterogeneity in lupus nephritis.

Der E, Ranabothu S, Suryawanshi H, Akat KM, Clancy R, Morozov P, Kustagi M, Czuppa M, Izmirly P, Belmont HM, Wang T, Jordan N, Bornkamp N, Nwaukoni J, Martinez J, Goilav B, Buyon JP, Tuschl T, Putterman C.

JCI Insight. 2017 May 4;2(9). pii: 93009. doi: 10.1172/jci.insight.93009. eCollection 2017 May 4.

34.

Kidney Outcomes and Risk Factors for Nephritis (Flare/De Novo) in a Multiethnic Cohort of Pregnant Patients with Lupus.

Buyon JP, Kim MY, Guerra MM, Lu S, Reeves E, Petri M, Laskin CA, Lockshin MD, Sammaritano LR, Branch DW, Porter TF, Sawitzke A, Merrill JT, Stephenson MD, Cohn E, Salmon JE.

Clin J Am Soc Nephrol. 2017 Jun 7;12(6):940-946. doi: 10.2215/CJN.11431116. Epub 2017 Apr 11.

35.

Activated Platelets Induce Endothelial Cell Activation via an Interleukin-1β Pathway in Systemic Lupus Erythematosus.

Nhek S, Clancy R, Lee KA, Allen NM, Barrett TJ, Marcantoni E, Nwaukoni J, Rasmussen S, Rubin M, Newman JD, Buyon JP, Berger JS.

Arterioscler Thromb Vasc Biol. 2017 Apr;37(4):707-716. doi: 10.1161/ATVBAHA.116.308126. Epub 2017 Feb 2.

36.

Ro52 autoantibodies arise from self-reactive progenitors in a mother of a child with neonatal lupus.

Reed JH, Gorny MK, Li L, Cardozo T, Buyon JP, Clancy RM.

J Autoimmun. 2017 May;79:99-104. doi: 10.1016/j.jaut.2017.01.004. Epub 2017 Jan 22.

37.

Digestion of Chromatin in Apoptotic Cell Microparticles Prevents Autoimmunity.

Sisirak V, Sally B, D'Agati V, Martinez-Ortiz W, Özçakar ZB, David J, Rashidfarrokhi A, Yeste A, Panea C, Chida AS, Bogunovic M, Ivanov II, Quintana FJ, Sanz I, Elkon KB, Tekin M, Yalçınkaya F, Cardozo TJ, Clancy RM, Buyon JP, Reizis B.

Cell. 2016 Jun 30;166(1):88-101. doi: 10.1016/j.cell.2016.05.034. Epub 2016 Jun 9.

38.

Modulation of natural IgM autoantibodies to oxidative stress-related neo-epitopes on apoptotic cells in newborns of mothers with anti-Ro autoimmunity.

Grönwall C, Clancy RM, Getu L, Lloyd KA, Siegel DL, Reed JH, Buyon JP, Silverman GJ.

J Autoimmun. 2016 Sep;73:30-41. doi: 10.1016/j.jaut.2016.05.014. Epub 2016 Jun 8.

39.

Brief Report: Changes in Antiphospholipid Antibody Titers During Pregnancy: Effects on Pregnancy Outcomes.

Yelnik CM, Porter TF, Branch DW, Laskin CA, Merrill JT, Guerra MM, Lockshin MD, Buyon JP, Petri M, Sammaritano LR, Stephenson MD, Kim MY, Salmon JE.

Arthritis Rheumatol. 2016 Aug;68(8):1964-9. doi: 10.1002/art.39668.

40.

Assessment of fluorinated steroids to avert progression and mortality in anti-SSA/Ro-associated cardiac injury limited to the fetal conduction system.

Izmirly PM, Saxena A, Sahl SK, Shah U, Friedman DM, Kim MY, Buyon JP.

Ann Rheum Dis. 2016 Jun;75(6):1161-5. doi: 10.1136/annrheumdis-2015-208311. Epub 2015 Dec 1.

41.

Lupus anticoagulant is the main predictor of adverse pregnancy outcomes in aPL-positive patients: validation of PROMISSE study results.

Yelnik CM, Laskin CA, Porter TF, Branch DW, Buyon JP, Guerra MM, Lockshin MD, Petri M, Merrill JT, Sammaritano LR, Kim MY, Salmon JE.

Lupus Sci Med. 2016 Jan 12;3(1):e000131. doi: 10.1136/lupus-2015-000131. eCollection 2016.

42.

Predictors of Pregnancy Outcomes in Patients With Lupus.

Buyon JP, Kim MY, Salmon JE.

Ann Intern Med. 2016 Jan 19;164(2):131. doi: 10.7326/L15-0500. No abstract available.

PMID:
26784479
43.

Autoimmune congenital heart block: complex and unusual situations.

Brito-Zerón P, Izmirly PM, Ramos-Casals M, Buyon JP, Khamashta MA.

Lupus. 2016 Feb;25(2):116-28. doi: 10.1177/0961203315624024. Review.

PMID:
26762645
44.

Endosomal Toll-like receptors in clinically overt and silent autoimmunity.

Clancy RM, Markham AJ, Buyon JP.

Immunol Rev. 2016 Jan;269(1):76-84. doi: 10.1111/imr.12383. Review.

45.

Targeting downstream transcription factors and epigenetic modifications following Toll-like receptor 7/8 ligation to forestall tissue injury in anti-Ro60 associated heart block.

Clancy RM, Markham AJ, Reed JH, Blumenberg M, Halushka MK, Buyon JP.

J Autoimmun. 2016 Feb;67:36-45. doi: 10.1016/j.jaut.2015.09.003. Epub 2015 Oct 1.

46.

Angiogenic factor imbalance early in pregnancy predicts adverse outcomes in patients with lupus and antiphospholipid antibodies: results of the PROMISSE study.

Kim MY, Buyon JP, Guerra MM, Rana S, Zhang D, Laskin CA, Petri M, Lockshin MD, Sammaritano LR, Branch DW, Porter TF, Merrill JT, Stephenson MD, Gao Q, Karumanchi SA, Salmon JE.

Am J Obstet Gynecol. 2016 Jan;214(1):108.e1-108.e14. doi: 10.1016/j.ajog.2015.09.066. Epub 2015 Sep 29.

47.

Serum Biomarkers of Inflammation, Fibrosis, and Cardiac Function in Facilitating Diagnosis, Prognosis, and Treatment of Anti-SSA/Ro-Associated Cardiac Neonatal Lupus.

Saxena A, Izmirly PM, Han SW, Briassouli P, Rivera TL, Zhong H, Friedman DM, Clancy RM, Buyon JP.

J Am Coll Cardiol. 2015 Aug 25;66(8):930-9. doi: 10.1016/j.jacc.2015.06.1088. Erratum in: J Am Coll Cardiol. 2015 Oct 20;66(16):1849.

48.

Efficacy and safety of subcutaneous tabalumab, a monoclonal antibody to B-cell activating factor, in patients with systemic lupus erythematosus: results from ILLUMINATE-2, a 52-week, phase III, multicentre, randomised, double-blind, placebo-controlled study.

Merrill JT, van Vollenhoven RF, Buyon JP, Furie RA, Stohl W, Morgan-Cox M, Dickson C, Anderson PW, Lee C, Berclaz PY, Dörner T.

Ann Rheum Dis. 2016 Feb;75(2):332-40. doi: 10.1136/annrheumdis-2015-207654. Epub 2015 Aug 20.

PMID:
26293163
49.

A highlight from the LUPUS 2014 meeting: eight great ideas.

Buyon JP, Cohen P, Merrill JT, Gilkeson G, Kaplan M, James J, McCune WJ, Bernatsky S, Elkon K.

Lupus Sci Med. 2015 Jun 30;2(1):e000087. doi: 10.1136/lupus-2015-000087. eCollection 2015. Review.

50.

Predictors of Pregnancy Outcomes in Patients With Lupus: A Cohort Study.

Buyon JP, Kim MY, Guerra MM, Laskin CA, Petri M, Lockshin MD, Sammaritano L, Branch DW, Porter TF, Sawitzke A, Merrill JT, Stephenson MD, Cohn E, Garabet L, Salmon JE.

Ann Intern Med. 2015 Aug 4;163(3):153-63. doi: 10.7326/M14-2235.

Supplemental Content

Loading ...
Support Center